{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:58:15Z","timestamp":1793116695597,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672495"],"award-info":[{"award-number":["81672495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771489"],"award-info":[{"award-number":["81771489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071558"],"award-info":[{"award-number":["82071558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071559"],"award-info":[{"award-number":["82071559"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072804"],"award-info":[{"award-number":["82072804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.drup.2024.101056","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T12:03:19Z","timestamp":1705665799000},"page":"101056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs"],"prefix":"10.1016","volume":"73","author":[{"given":"Jianhua","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2024.101056_bib1","doi-asserted-by":"crossref","first-page":"eabl3674","DOI":"10.1126\/sciadv.abl3674","article-title":"Personalized chordoma organoids for drug discovery studies","volume":"8","author":"Al Shihabi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2024.101056_bib2","first-page":"1","article-title":"Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis","author":"Ben-Shlomo","year":"2023","journal-title":"Pituitary"},{"key":"10.1016\/j.drup.2024.101056_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101056_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer\u2013derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2024.101056_bib5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3390\/cancers14071600","article-title":"Elucidation of focal adhesion kinase as a modulator of migration and invasion and as a potential therapeutic target in chronic lymphocytic leukemia","volume":"14","author":"Burley","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2024.101056_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12020-015-0824-2","article-title":"Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas","volume":"52","author":"Cai","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.drup.2024.101056_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2021.11.026","article-title":"Den Berghe, PKC\u03b8-mediated serine\/threonine phosphorylations of FAK govern adhesion and protrusion dynamics within the lamellipodia of migrating breast cancer cells","volume":"526","author":"Chadelle","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2024.101056_bib8","doi-asserted-by":"crossref","unstructured":"P. Chanson and D. Maiter, The epidemiology, diagnosis and treatment of Prolactinomas: The old an d the new, Best Pract Res Clin Endocrinol Metab 33, p. 101290.","DOI":"10.1016\/j.beem.2019.101290"},{"key":"10.1016\/j.drup.2024.101056_bib9","article-title":"Human liver cancer organoids: biological applications, current challenges, and prospects in hepatoma therapy","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2024.101056_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111140","article-title":"CircNFIX promotes progression of pituitary adenoma via CCNB1 by sponging miR-34a-5p","volume":"525","author":"Cheng","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.drup.2024.101056_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2022.102559","article-title":"A nanomechanical strategy involving focal adhesion kinase for overcoming drug resistance in breast cancer","volume":"43","author":"Choi","year":"2022","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.drup.2024.101056_bib12","doi-asserted-by":"crossref","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","article-title":"A brief history of organoids","volume":"319","author":"Corr\u00f2","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.drup.2024.101056_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11102-018-0877-3","article-title":"Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas","volume":"21","author":"Dogansen","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.drup.2024.101056_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2024.101056_bib15","series-title":"Seminars in cancer biology","first-page":"65","article-title":"Focal adhesion signaling and therapy resistance in cancer","author":"Eke","year":"2015"},{"key":"10.1016\/j.drup.2024.101056_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215585","article-title":"DGKA interacts with SRC\/FAK to promote the metastasis of non-small cell lung cancer","volume":"532","author":"Fu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2024.101056_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153604","article-title":"Update in pathogenesis, diagnosis, and therapy of prolactinoma","volume":"14","author":"Fukuhara","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2024.101056_bib18","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/cancers14153604","article-title":"Update in pathogenesis, diagnosis, and therapy of prolactinoma","volume":"14","author":"Fukuhara","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2024.101056_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153950","article-title":"Focal adhesion proteins in hepatocellular carcinoma: RSU1 a novel tumour suppressor with prognostic significance","volume":"235","author":"Geramoutsou","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.drup.2024.101056_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fendo.2018.00625","article-title":"Prolactinomas resistant to treatment with dopamine agonists: long-term follow-up of six cases","volume":"9","author":"Gonzaga","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.drup.2024.101056_bib21","series-title":"Annales d\u2032endocrinologie","first-page":"84","article-title":"Pasireotide: A potential therapeutic alternative for resistant prolactinoma","author":"Lasolle","year":"2019"},{"key":"10.1016\/j.drup.2024.101056_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11102-019-01000-7","article-title":"Aggressive prolactinomas: how to manage?","volume":"23","author":"Lasolle","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.drup.2024.101056_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.wneu.2018.02.188","article-title":"Combination treatment with bromocriptine and metformin in patients with bromocriptine-resistant prolactinomas: pilot study","volume":"115","author":"Liu","year":"2018","journal-title":"World Neurosurg."},{"key":"10.1016\/j.drup.2024.101056_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of dopamine agonist-resistant prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.drup.2024.101056_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","article-title":"Management of medically refractory prolactinoma","volume":"117","author":"Molitch","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.drup.2024.101056_bib26","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","article-title":", Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro-and macroprolactinomas","volume":"95","author":"Ono","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2024.101056_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000156116","article-title":"Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists","volume":"89","author":"Passos","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.drup.2024.101056_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/jcem-69-3-500","article-title":"Resistance to bromocriptine in prolactinomas","volume":"69","author":"Pellegrini","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drup.2024.101056_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100906","article-title":"CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis","volume":"66","author":"Qin","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2024.101056_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BST20180375","article-title":"Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer","volume":"47","author":"Roelofs","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drup.2024.101056_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02154-8","article-title":"Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects","volume":"40","author":"Romito","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2024.101056_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.foodchem.2015.09.085","article-title":"Understanding genistein in cancer: the \u201cgood\u201d and the \u201cbad\u201d effects: a review","volume":"196","author":"Russo","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.drup.2024.101056_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/a-1525-2131","article-title":"Treatment strategies for dopamine agonist-resistant and aggressive prolactinomas: a comprehensive analysis of the literature","volume":"53","author":"Sari","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.drup.2024.101056_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41418-020-00662-2","article-title":"Gastric organoids\u2014an in vitro model system for the study of gastric development and road to personalized medicine","volume":"28","author":"Seidlitz","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drup.2024.101056_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11102-019-00987-3","article-title":"Dopamine agonist resistant prolactinomas: any alternative medical treatment?","volume":"23","author":"Souteiro","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.drup.2024.101056_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.4576","article-title":"Organoids","volume":"15","author":"de Souza","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2024.101056_bib37","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1177\/0300060519848916","article-title":"Increased expression of aromatase cytochrome P450 enzyme is associated with prolactinoma invasiveness in post-menopausal women","volume":"47","author":"Su","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.drup.2024.101056_bib38","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-2887","article-title":"Three dimensional colon cancer organoids model the response to CEA CD3 T cell engagers","volume":"82","author":"Teijeira","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2024.101056_bib39","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.7150\/jca.66248","article-title":"Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer","volume":"13","author":"Tong","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.drup.2024.101056_bib40","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1158\/0008-5472.CAN-06-2387","article-title":"Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis","volume":"66","author":"Verma","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2024.101056_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000497746","article-title":"Epidemiology and management challenges in prolactinomas","volume":"109","author":"Vroonen","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.drup.2024.101056_bib42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s11596-008-0518-6","article-title":"The expression of integrin\u03b21 and FAK in pituitary adenomas and their correlation with invasiveness","volume":"28","author":"Wang","year":"2008","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.drup.2024.101056_bib43","article-title":"Patient-derived organoids in translational oncology and drug screening","author":"Yang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2024.101056_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics: a J. Integr. Biol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:07:51Z","timestamp":1761282471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764624000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":44,"alternative-id":["S1368764624000141"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101056","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101056"}}